{
  "meta": {
    "title": "Other_Auto-Immune_Disorders",
    "url": "https://brainandscalpel.vercel.app/other-auto-immune-disorders-467c531d.html",
    "scrapedAt": "2025-11-29T18:32:11.152Z"
  },
  "questions": [
    {
      "id": 14205,
      "choices": [
        {
          "id": 56781,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid-stimulating hormone (TSH) receptor </span></span></span></p>"
        },
        {
          "id": 56782,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium channel</span></span></span></p>"
        },
        {
          "id": 56783,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine receptor </span></span></span></p>"
        },
        {
          "id": 56784,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid factor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A middle-aged lady 30-year-old woman complains of diplopia and drooping eyelids. She undergoes investigation which reveals a mediastinal mass. The symptoms of muscle weakness in this patient are caused by antibodies directed against which of the following cellular components?</span></span></span></p>",
      "unique_key": "Q5060534",
      "question_audio": null,
      "question_video": null,
      "map_id": 31885,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Acetylcholine receptor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Myasthenia gravis </strong>is a <strong>type II hypersensitivity disorder </strong>caused by<strong> antibodies </strong>that <strong>bind to the acetylcholine receptor.</strong> These <strong>antibodies interfere</strong> with the <strong>transmission of neural impulses </strong>at the <strong>neuromuscular junctio</strong>n, causing <strong>muscle weakness and easy fatigability. External ocular and eyelid muscles </strong>are most often affected, but the disease is <strong>often progressive and may cause death by respiratory muscle paralysis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Antibodies </strong>directed against the <strong>acetylcholine receptor </strong>at the <strong>neuromuscular junction </strong>are characteristic of <strong>myasthenia gravis</strong>. This condition often presents with o<strong>cular symptoms like diplopia and ptosis </strong>and may be associated with a <strong>thymoma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Thyroid-stimulating hormone (TSH) receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Antibodies </strong>against the<strong> TSH receptor </strong>are characteristic of <strong>Graves&#39; disease</strong>, an autoimmune disorder that leads to<strong> hyperthyroidism</strong>, not typically associated with muscle weakness.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Calcium channel:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Antibodies to calcium channels </strong>is associated with <strong>Lambert-Eaton myasthenic syndrome, </strong>which can cause<strong> muscle weakness; </strong>however, the presence of a <strong>mediastinal mass is more suggestive of thymoma </strong>associated with <strong>myasthenia gravis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Rheumatoid factor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rheumatoid factor is an <strong>autoantibody </strong>observed in <strong>rheumatoid arthritis, </strong>which primarily affects joints and is not typically involved in th<strong>e neuromuscular transmission </strong>pathology seen in <strong>myasthenia gravis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of a<strong> mediastinal mass </strong>and symptoms such as <strong>diplopia and ptosis in a young adult </strong>are highly suggestive of <strong>myasthenia gravis</strong>, which is caused by<strong> autoantibodies against the acetylcholine receptor, </strong>leading to<strong> muscle weakness. </strong></span></span></p>",
      "correct_choice_id": 56783,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15522,
      "choices": [
        {
          "id": 62048,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diminished calcium in the sarcoplasmic reticulum</span></span></span></p>"
        },
        {
          "id": 62049,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against the sarcoplasmic reticulum</span></span></span></p>"
        },
        {
          "id": 62050,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accelerated uptake of the neurotransmitter at the nerve-muscle junction</span></span></span></p>"
        },
        {
          "id": 62051,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against presynaptic channels at the nerve-muscle junction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 67-year-old male with a history of smoking and a recent diagnosis of small-cell lung carcinoma presents with a chief complaint of increasing weakness, particularly in the proximal muscles of his limbs. He reports that the weakness improves with repeated use of the muscles. Electromyography reveals a decremental response in muscle action potential amplitude with low-frequency stimulation, which improves with high-frequency stimulation. </span></span><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of muscle weakness in Lambert-Eaton syndrome is which of the following? </span></span></p>",
      "unique_key": "Q2087031",
      "question_audio": null,
      "question_video": null,
      "map_id": 31884,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans D) Antibody against presynaptic channels at the nerve-muscle junction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical scenario, <strong>weakness in the proximal muscle groups</strong>, associated with a <strong>pulmonary neoplasm </strong>with metastases, is consistent with <strong>Lambert-Eaton syndrome</strong> associated with <strong>small-cell carcinoma</strong>. In Lambert-Eaton syndrome, the tumor causes the production of an <strong><em>antibody directed against the presynaptic calcium channels</em></strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against presynaptic channels at the nerve-muscle junction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the correct mechanism. In <strong>Lambert-Eaton syndrome</strong>, <strong>antibodies </strong>target the <strong>voltage-gated calcium channels </strong>on the <strong>presynaptic terminal</strong>, <strong>impairing </strong>the <strong>release of acetylcholine</strong>, and thus leading to <strong>muscle weakness</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diminished calcium in the sarcoplasmic reticulum </strong>would <strong>affect muscle contraction </strong>but is <strong>not the mechanism of muscle weakness </strong>seen in Lambert-Eaton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>antibody against the sarcoplasmic reticulum</strong> is <strong>not associated with Lambert-Eaton syndrome</strong>. Antibodies in LEMS are directed against voltage-gated calcium channels on the presynaptic nerve terminal, not against the sarcoplasmic reticulum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Accelerated uptake of neurotransmitter at the nerve-muscle junction</strong> would likely lead to a <strong>decrease in available neurotransmitter </strong>for <strong>muscle contraction</strong>, but this is not the pathophysiology of Lambert-Eaton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle weakness </strong>in <strong>Lambert-Eaton syndrome </strong>is due to <strong>antibodies against presynaptic voltage-gated calcium channels </strong>at the <strong>nerve-muscle junction</strong>, impairing acetylcholine release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1226</span></strong></span></span></p>",
      "correct_choice_id": 62051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}